| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut für Tierpathologie (LNB, AG), Institut für Veterinär-Bakteriologie (PB, JF), and Pferdeklinik (RS),Universität Bern, Berne, Switzerland
Clostridia-associated intestinal disease in horses was generally reported to be due to infection with Clostridium perfringens type A, which harbors the cpa-encoded 
-toxin. A recent study demonstrated a high incidence of ß2-toxigenic C. perfringens in horses suffering or dying from typhlocolitis, suggesting that this novel type of C. perfringens might play an important role in typhlocolitis and possibly other equine intestinal diseases. A retrospective study was conducted to assess the presence of the ß2-toxin in tissues of the equine gastrointestinal tract. Monospecific polyclonal antibodies against recombinant ß2-toxin were produced in rabbits and used to demonstrate the ß2-toxin in sections of the gastrointestinal tract by immunohistochemical methods. Sections from 69 horses were stained and ß2-toxin was observed immunohistochemically in 40 animals. Sections from the stomach, small intestine, and large intestine were positive. Immunopositivity for ß2-toxin was significantly associated with presence of ß2-toxigenic bacteria. This investigation demonstrates local production of ß2-toxin and suggests that immunohistochemistry using antitoxin antibodies represents a useful diagnostic method in those cases where isolation of bacteria and polymerase chain reaction typing is not feasible. Although the association between the presence of ß2-toxin and development of gastrointestinal disease in horses remains uncertain, the findings of this study indicate that the potential causal relationship warrants further investigation.
Key words: ß2-toxin; Clostridium perfringens; gastrointestinal tract; horses; immunohistochemistry.
Request reprints from Dr. L. N. Bacciarini, Ufficio veterinario cantonale, Via Dogana 16, CH-6500 Bellinzona (Switzerland). E-mail: luca.bacciarini{at}ti.ch.
This article has been cited by other articles:
 |
|
 |
|
  F. A. Uzal, D. J. Fisher, J. Saputo, S. Sayeed, B. A. McClane, G. Songer, H. T. Trinh, M. E. Fernandez Miyakawa, and S. Gard Ulcerative enterocolitis in two goats associated with enterotoxin- and beta2 toxin-positive Clostridium perfringens type D J Vet Diagn Invest, September 1, 2008; 20(5): 668 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Keyburn, S. A. Sheedy, M. E. Ford, M. M. Williamson, M. M. Awad, J. I. Rood, and R. J. Moore Alpha-Toxin of Clostridium perfringens Is Not an Essential Virulence Factor in Necrotic Enteritis in Chickens Infect. Immun., November 1, 2006; 74(11): 6496 - 6500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Harrison, D. Raju, H. S. Garmory, M. M. Brett, R. W. Titball, and M. R. Sarker Molecular Characterization of Clostridium perfringens Isolates from Humans with Sporadic Diarrhea: Evidence for Transcriptional Regulation of the Beta2-Toxin-Encoding Gene Appl. Envir. Microbiol., December 1, 2005; 71(12): 8362 - 8370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Waters, D. Raju, H. S. Garmory, M. R. Popoff, and M. R. Sarker Regulated Expression of the Beta2-Toxin Gene (cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases J. Clin. Microbiol., August 1, 2005; 43(8): 4002 - 4009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Jost, S. J. Billington, H. T. Trinh, D. M. Bueschel, and J. G. Songer Atypical cpb2 Genes, Encoding Beta2-Toxin in Clostridium perfringens Isolates of Nonporcine Origin Infect. Immun., January 1, 2005; 73(1): 652 - 656. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
